Consultation document 

The National Institute for Health and Care Excellence (NICE) is producing guidance on Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway. The diagnostics advisory committee has considered the evidence and the views of clinical and patient experts.   

You can now comment on the diagnostics consultation document and the Evidence Generation plan.  

The guidance summarises the evidence and views that have been considered, and sets out the recommendations made by the committee. The evidence generation plan outlines the evidence gaps and what real-world data needs to be collected for a NICE review of the technologies again in the future. NICE invites comments from registered stakeholders, healthcare professionals and the public.  

How to comment 

You should read the consultation document, evidence generation plan and the accompanying evidence (see the committee papers) before making any comments. 

You must make your comments directly onto the online version of the consultation document. When you go into the document you will find instructions on how to use the new commenting software.  You can also review and edit your comments before you submit them. If you wish to comment on both documents, please add your comments to BOTH documents before submitting them.

You can download a PDF version of the consultation document and the evidence generation plan, but you can only make comments on the online version. 

Consultation documents: 

  • Supporting documentation:  
  • Committee papers 1, Overview, External Assessment report (EAR), Organisational submission, EAR comments and EAG responses.  

Closing date for comments: 25 September 2024 at 5pm 

About the consultation 

The advisory committee is interested in receiving comments on the following: 

  • Has all of the relevant evidence been taken into account? 
  • Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence? 
  • Are the recommendations sound, and a suitable basis for guidance to the NHS? 
  • Evidence generation plan specific - Please could you consider the different options for comparison against a reference standard in the diagnostic accuracy study. Which option do you think may be the best approach to address the evidence gaps identified by the committee? 

Equality issues 

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with particular protected characteristics and others. Please let us know if you think that the recommendations may need changing to meet these aims. In particular, please tell us if the recommendations: 

  • could have a different effect on people protected by the equality legislation than on the wider population, for example by making it more difficult in practice for a specific group to access the technology 
  • could have any adverse effect on people with a particular disability or disabilities. 

Please provide any relevant information or data you have about such effects and how they could be avoided or reduced. 

Note that this document is not NICE's final guidance on these technologies. The recommendations in section 1 may change after consultation. 

After consultation, the comments will be considered and the final recommendations will be prepared for publication.  

Find out more 

For further details, see the Early Value Assessment interim statement 

If you have any problems, contact diagnostics@nice.org.uk